Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BIO Medicare Drug Benefit Radio Spots Will Air Until Congressional Recess

Executive Summary

The Biotechnology Industry Organization is broadcasting a two-week, warm-up campaign on the Medicare drug benefit to the inside-the-Beltway audience before Congress breaks for the summer.

You may also be interested in...



BIO Medicare Campaign

The Biotechnology Industry Organization targets President Clinton with its second series of Medicare reform-focused radio ads to be aired on a Martha's Vineyard, Mass. radio station during Clinton's vacation on the island. The ads, which first ran in Washington, D.C. during the two weeks before the congressional recess, focus on the lack of stop-loss coverage for potentially expensive biotech products in the Administration's Medicare drug benefit proposal (1"The Pink Sheet" Aug. 2, p. 13). The Martha's Vineyard ads are scheduled to run through Aug. 30

BIO Medicare Campaign

The Biotechnology Industry Organization targets President Clinton with its second series of Medicare reform-focused radio ads to be aired on a Martha's Vineyard, Mass. radio station during Clinton's vacation on the island. The ads, which first ran in Washington, D.C. during the two weeks before the congressional recess, focus on the lack of stop-loss coverage for potentially expensive biotech products in the Administration's Medicare drug benefit proposal (1"The Pink Sheet" Aug. 2, p. 13). The Martha's Vineyard ads are scheduled to run through Aug. 30

Medicare Rx Drug Payment Review Commission Returns In Sen. Grams' Bill

Sen. Grams (R-Minn.) is reviving the Medicare Prescription Drug Payment Review Commission previously proposed by Rep. Stark (D-Calif.) during the 1994 health care reform debates.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034581

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel